Ugur Sener

Neuro-oncologist @MayoClinicNeuro. Views are my own.

[Bryan Neth, MD, PhD @bryanneth]

An important paper from our experience @MayoClinic with bevacizumab in NF2 - vestibular schwannoma. Discontinuation of bevacizumab may lead to rapid VS growth and should prompt close surveillance. Lead by @UgurSenerMD and Mason Webb. https://t.co/vwDnBi6o1K

[PDBrown @PDBrownOnc]

IDH Wildtype Astrocytoma, does isolated TERT Promoter Mutation in histologic Grade 2 equate to GBM prognosis?

Probably NOT, isolated TERT have better prognosis https://t.co/npnN3xcQn1

[The Yang Lab @TheYangLab1]

Check out the latest Journal Highlight @CNS_Update by our very own Vera Ong on Gender-Based Disparities in Academic Productivity During Neurosurgery Residency! @IsaacYangMD @VeraPadlanOng @NSTumorSection @UCLANsgy @ManishKAghi @NeurosurgUCSF

Link: https://t.co/Oyo93Qslym

[Maciej M Mrugala, MD, PhD, MPH, FAAN @MrugalaMaciej]

Check out the content of our new book - Neuro-Oncology Compendium for the Boards and Clinical Practice - available now!!!! Proud to have worked with Drs. Gatson, Clarke, Kurtz and Nevel on this 📖 @OUPMedicine
https://t.co/Rq5QEicAKG

[PDBrown @PDBrownOnc]

Does molecular GBM have better prog compared to histologic GBM?
NO, according to this Dutch study
Compared histologically&imagingGr2/3 but molecular GBM to histologic GBM
https://t.co/6t6x8hNeLE

[Ian F. Parney MD PhD @IanParneyMDPhD]

Very exciting and translatable work from Zach Tritz in Aaron Johnson’s lab!

[Ugur Sener @UgurSenerMD]

Positive results from Indigo trial presented by Dr. Mellinghoff at #ASCO today. Vorasidenib compared to placebo associated with prolonged PFS and time to next treatment for patients with low grade #glioma.

[PDBrown @PDBrownOnc]

What is prognosis of spinal cord mets from brain GBM?

14 patients, 86% spine mets treated
Median OS 3 mos
https://t.co/GoTAz2kXEY

[Ugur Sener @UgurSenerMD]

Happy to be part of an excellent review on vaccine based therapies for GBM from @BryanNeth https://t.co/KaOeyQYSJ3

[NCI Cancer Stats @NCICancerStats]

#BrainCancer is most frequently diagnosed in people between ages 55 and 74 years. The median age of diagnosis is 60. Visit our Cancer Stat Facts sheet—now with updated data—for more cancer statistics: https://t.co/L2LuXfQkWz #BrainTumorThursday

[PDBrown @PDBrownOnc]

In GBM is there a role for “supramaximal” resection of FLAIR/T2 tumor beyond contrast enhancing tumor?
· RANO resect group study would suggest YES
· Thought provoking study difficult to tease out inherent selection bias (favorable location, smaller tumor)
https://t.co/oq0UxCdL8w

[Maciej M Mrugala, MD, PhD, MPH, FAAN @MrugalaMaciej]

Neuro-Oncology Scientific Award in Neuro-Oncology #AANAM goes to Ingo Mellinghoff @MSKCancerCenter - congratulations on this well deserved award!!!